Skip to main content

Advertisement

SpringerLink
Log in

Infliximab for Behçet disease with aortic involvement: two novel case reports without concurrent use of immunosuppressive agents or corticosteroids

  • Rapid Communication
  • Published:
Modern Rheumatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Yazici H. Behçet’s syndrome: where do we stand? Am J Med. 2002;112:75–6.

    Article  PubMed  Google Scholar 

  2. Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y, Ohokubo T. Pathologic features of Behçet’s syndrome: a review of Japanese autopsy registry data. Hum Pathol. 1985;16:790–5.

    Article  PubMed  CAS  Google Scholar 

  3. Saadoun D, Asli B, Wechsler B, Houman H, Geri G, Desseaux K, et al. Long-term outcome of arterial lesions in Behçet disease: a series of 101 patients. Medicine. 2012;91:18–24.

    Article  PubMed  Google Scholar 

  4. Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, et al. Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis. 2009;68:1528–34.

    Article  PubMed  CAS  Google Scholar 

  5. Arida A, Fragiadaki K, Giavri E, Sfikakis PP. Anti-TNF agents for Behcet’s disease: analysis of published data on 369 patients. Semin Arthritis Rheum. 2011;41:61–70.

    Article  PubMed  CAS  Google Scholar 

  6. Adler S, Baumgartner I, Villiger PM. Behçet’s disease: successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis. Arthritis Care Res. 2012;64(4):607–11.

    Article  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Division of Allergy and Rheumatology, St. Luke’s International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan

    Ryo Rokutanda, Masato Okada, Kenichi Yamaguchi & Mitsumasa Kishimoto

  2. Department of Radiology, St. Luke’s International Hospital, Tokyo, Japan

    Taiki Nozaki

  3. St. Luke’s Life Science Institute Center for Clinical Epidemiology, Tokyo, Japan

    Gautam A. Deshpande

Authors
  1. Ryo Rokutanda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masato Okada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kenichi Yamaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Taiki Nozaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gautam A. Deshpande
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mitsumasa Kishimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ryo Rokutanda.

About this article

Cite this article

Rokutanda, R., Okada, M., Yamaguchi, K. et al. Infliximab for Behçet disease with aortic involvement: two novel case reports without concurrent use of immunosuppressive agents or corticosteroids. Mod Rheumatol 23, 412–413 (2013). https://doi.org/10.1007/s10165-012-0721-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10165-012-0721-y

Keywords

Search

Navigation